{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:51:21Z","timestamp":1791474681251,"version":"4.3.4"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T00:00:00Z","timestamp":1508284800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s00277-017-3151-2","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T02:07:34Z","timestamp":1508292454000},"page":"17-29","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Transformed follicular lymphoma"],"prefix":"10.1007","volume":"97","author":[{"given":"Thais","family":"Fischer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia Pin Chuen","family":"Zing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Sergio","family":"Chiattone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Federico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Luminari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,18]]},"reference":[{"issue":"5","key":"3151_CR1","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","volume":"84","author":"NL Harris","year":"1994","unstructured":"Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML et al (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84(5):1361\u20131392","journal-title":"Blood"},{"issue":"12","key":"3151_CR2","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"NL Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J et al (1999) World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 17(12):3835\u20133849. https:\/\/doi.org\/10.1200\/JCO.1999.17.12.3835","journal-title":"J Clin Oncol"},{"issue":"5","key":"3151_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1053\/j.seminoncol.2009.07.009","volume":"36","author":"SM Jaglowski","year":"2009","unstructured":"Jaglowski SM, Linden E, Termuhlen AM, Flynn JM (2009) Lymphoma in adolescents and young adults. Semin Oncol 36(5):381\u2013418. https:\/\/doi.org\/10.1053\/j.seminoncol.2009.07.009","journal-title":"Semin Oncol"},{"issue":"5","key":"3151_CR4","doi-asserted-by":"crossref","first-page":"484","DOI":"10.6004\/jnccn.2011.0046","volume":"9","author":"AD Zelenetz","year":"2011","unstructured":"Zelenetz AD, Abramson JS, Advani RH, Andreadis CB, Bartlett N, Bellam N et al (2011) Non-Hodgkin\u2019s lymphomas. J Natl Compr Cancer Netw 9(5):484\u2013560","journal-title":"J Natl Compr Cancer Netw"},{"issue":"3","key":"3151_CR5","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/leu.2014.251","volume":"29","author":"HR Junlen","year":"2015","unstructured":"Junlen HR, Peterson S, Kimby E, Lockmer S, Linden O, Nilsson-Ehle H et al (2015) Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry study. Leukemia 29(3):668\u2013676. https:\/\/doi.org\/10.1038\/leu.2014.251","journal-title":"Leukemia"},{"issue":"1","key":"3151_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1309\/TNKL-7GDC-66R9-WPV5","volume":"121","author":"N Bilalovic","year":"2004","unstructured":"Bilalovic N, Blystad AK, Golouh R, Nesland JM, Selak I, Trinh D et al (2004) Expression of bcl-6 and CD10 protein is associated with longer overall survival and time to treatment failure in follicular lymphoma. Am J Clin Pathol 121(1):34\u201342. https:\/\/doi.org\/10.1309\/TNKL-7GDC-66R9-WPV5","journal-title":"Am J Clin Pathol"},{"issue":"22","key":"3151_CR7","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1200\/JCO.2005.04.503","volume":"23","author":"WT Swenson","year":"2005","unstructured":"Swenson WT, Wooldridge JE, Lynch CF, Forman-Hoffman VL, Chrischilles E, Link BK (2005) Improved survival of follicular lymphoma patients in the United States. J Clin Oncol 23(22):5019\u20135026. https:\/\/doi.org\/10.1200\/JCO.2005.04.503","journal-title":"J Clin Oncol"},{"issue":"4","key":"3151_CR8","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1182\/blood-2014-04-571786","volume":"125","author":"C Correia","year":"2015","unstructured":"Correia C, Schneider PA, Dai H, Dogan A, Maurer MJ, Church AK et al (2015) BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma. Blood 125(4):658\u2013667. https:\/\/doi.org\/10.1182\/blood-2014-04-571786","journal-title":"Blood"},{"issue":"19","key":"3151_CR9","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJM198711053171904","volume":"317","author":"LM Weiss","year":"1987","unstructured":"Weiss LM, Warnke RA, Sklar J, Cleary ML (1987) Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med 317(19):1185\u20131189. https:\/\/doi.org\/10.1056\/NEJM198711053171904","journal-title":"N Engl J Med"},{"issue":"5","key":"3151_CR10","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1200\/JCO.1988.6.5.919","volume":"6","author":"JD Rowley","year":"1988","unstructured":"Rowley JD (1988) Chromosome studies in the non-Hodgkin's lymphomas: the role of the 14;18 translocation. J Clin Oncol 6(5):919\u2013925. https:\/\/doi.org\/10.1200\/JCO.1988.6.5.919","journal-title":"J Clin Oncol"},{"issue":"1","key":"3151_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2014-04-516815","volume":"125","author":"C Casulo","year":"2015","unstructured":"Casulo C, Burack WR, Friedberg JW (2015) Transformed follicular non-Hodgkin lymphoma. Blood 125(1):40\u201347. https:\/\/doi.org\/10.1182\/blood-2014-04-516815","journal-title":"Blood"},{"issue":"8","key":"3151_CR12","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1182\/blood.V82.8.2510.2510","volume":"82","author":"AC Lambrechts","year":"1993","unstructured":"Lambrechts AC, Hupkes PE, Dorssers LC, van't Veer MB (1993) Translocation (14;18)-positive cells are present in the circulation of the majority of patients with localized (stage I and II) follicular non-Hodgkin's lymphoma. Blood 82(8):2510\u20132516","journal-title":"Blood"},{"issue":"1","key":"3151_CR13","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1016\/S2352-3026(14)70008-0","volume":"1","author":"J Trotman","year":"2014","unstructured":"Trotman J, Luminari S, Boussetta S, Versari A, Dupuis J, Tychyj C et al (2014) Prognostic value of PET-CT after first-line therapy in patients with follicular lymphoma: a pooled analysis of central scan review in three multicentre studies. Lancet Haematol 1(1):e17\u2013e27. https:\/\/doi.org\/10.1016\/S2352-3026(14)70008-0","journal-title":"Lancet Haematol"},{"issue":"2","key":"3151_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.beha.2011.02.006","volume":"24","author":"IS Lossos","year":"2011","unstructured":"Lossos IS, Gascoyne RD (2011) Transformation of follicular lymphoma. Best Pract Res Clin Haematol 24(2):147\u2013163. https:\/\/doi.org\/10.1016\/j.beha.2011.02.006","journal-title":"Best Pract Res Clin Haematol"},{"issue":"22","key":"3151_CR15","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1200\/JCO.2015.65.7163","volume":"34","author":"C Sarkozy","year":"2016","unstructured":"Sarkozy C, Trneny M, Xerri L, Wickham N, Feugier P, Leppa S et al (2016) Risk factors and outcomes for patients with follicular lymphoma who had histologic transformation after response to first-line immunochemotherapy in the PRIMA trial. J Clin Oncol 34(22):2575\u20132582. https:\/\/doi.org\/10.1200\/JCO.2015.65.7163","journal-title":"J Clin Oncol"},{"issue":"9873","key":"3151_CR16","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/S0140-6736(12)61763-2","volume":"381","author":"MJ Rummel","year":"2013","unstructured":"Rummel MJ, Niederle N, Maschmeyer G, Banat GA, von Grunhagen U, Losem C et al (2013) Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. Lancet 381(9873):1203\u20131210. https:\/\/doi.org\/10.1016\/S0140-6736(12)61763-2","journal-title":"Lancet"},{"issue":"22","key":"3151_CR17","doi-asserted-by":"publisher","first-page":"9166","DOI":"10.1158\/0008-5472.CAN-10-2460","volume":"70","author":"KJ Cheung","year":"2010","unstructured":"Cheung KJ, Johnson NA, Affleck JG, Severson T, Steidl C, Ben-Neriah S et al (2010) Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis. Cancer Res 70(22):9166\u20139174. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-2460","journal-title":"Cancer Res"},{"issue":"1","key":"3151_CR18","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","volume":"6","author":"L Pasqualucci","year":"2014","unstructured":"Pasqualucci L, Khiabanian H, Fangazio M, Vasishtha M, Messina M, Holmes AB et al (2014) Genetics of follicular lymphoma transformation. Cell Rep 6(1):130\u2013140. https:\/\/doi.org\/10.1016\/j.celrep.2013.12.027","journal-title":"Cell Rep"},{"issue":"26","key":"3151_CR19","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1200\/JCO.2012.48.3990","volume":"31","author":"BK Link","year":"2013","unstructured":"Link BK, Maurer MJ, Nowakowski GS, Ansell SM, Macon WR, Syrbu SI et al (2013) Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa\/MayoClinic specialized program of research excellence molecular epidemiology resource. J Clin Oncol 31(26):3272\u20133278. https:\/\/doi.org\/10.1200\/JCO.2012.48.3990","journal-title":"J Clin Oncol"},{"issue":"3","key":"3151_CR20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1044-579X(03)00015-4","volume":"13","author":"IS Lossos","year":"2003","unstructured":"Lossos IS, Levy R (2003) Higher grade transformation of follicular lymphoma: phenotypic tumor progression associated with diverse genetic lesions. Semin Cancer Biol 13(3):191\u2013202","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"3151_CR21","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1182\/blood-2015-01-621375","volume":"126","author":"ND Wagner-Johnston","year":"2015","unstructured":"Wagner-Johnston ND, Link BK, Byrtek M, Dawson KL, Hainsworth J, Flowers CR et al (2015) Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS). Blood 126(7):851\u2013857. https:\/\/doi.org\/10.1182\/blood-2015-01-621375","journal-title":"Blood"},{"issue":"4","key":"3151_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/bjh.12570","volume":"163","author":"M Ban-Hoefen","year":"2013","unstructured":"Ban-Hoefen M, Vanderplas A, Crosby-Thompson AL, Abel GA, Czuczman MS, Gordon LI et al (2013) Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database. Br J Haematol 163(4):487\u2013495. https:\/\/doi.org\/10.1111\/bjh.12570","journal-title":"Br J Haematol"},{"issue":"9759","key":"3151_CR23","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S0140-6736(10)62175-7","volume":"377","author":"G Salles","year":"2011","unstructured":"Salles G, Seymour JF, Offner F, Lopez-Guillermo A, Belada D, Xerri L et al (2011) Rituximab maintenance for 2\u00a0years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial. Lancet 377(9759):42\u201351. https:\/\/doi.org\/10.1016\/S0140-6736(10)62175-7","journal-title":"Lancet"},{"issue":"17","key":"3151_CR24","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1200\/JCO.2006.09.3260","volume":"25","author":"S Montoto","year":"2007","unstructured":"Montoto S, Davies AJ, Matthews J, Calaminici M, Norton AJ, Amess J et al (2007) Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. J Clin Oncol 25(17):2426\u20132433. https:\/\/doi.org\/10.1200\/JCO.2006.09.3260","journal-title":"J Clin Oncol"},{"issue":"2","key":"3151_CR25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/1097-0142(197908)44:2<645::AID-CNCR2820440234>3.0.CO;2-Y","volume":"44","author":"MH Cullen","year":"1979","unstructured":"Cullen MH, Lister TA, Brearley RI, Shand WS, Stansfeld AG (1979) Histological transformation of non-Hodgkin's lymphoma: a prospective study. Cancer 44(2):645\u2013651","journal-title":"Cancer"},{"issue":"13","key":"3151_CR26","doi-asserted-by":"publisher","first-page":"8886","DOI":"10.1073\/pnas.132253599","volume":"99","author":"IS Lossos","year":"2002","unstructured":"Lossos IS, Alizadeh AA, Diehn M, Warnke R, Thorstenson Y, Oefner PJ et al (2002) Transformation of follicular lymphoma to diffuse large-cell lymphoma: alternative patterns with increased or decreased expression of c-myc and its regulated genes. Proc Natl Acad Sci U S A 99(13):8886\u20138891. https:\/\/doi.org\/10.1073\/pnas.132253599","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"3151_CR27","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1038\/sj.leu.2402578","volume":"16","author":"IS Lossos","year":"2002","unstructured":"Lossos IS, Warnke R, Levy R (2002) BCL-6 mRNA expression in higher grade transformation of follicle center lymphoma: correlation with somatic mutations in the 5\u2032 regulatory region of the BCL-6 gene. Leukemia 16(9):1857\u20131862. https:\/\/doi.org\/10.1038\/sj.leu.2402578","journal-title":"Leukemia"},{"issue":"8","key":"3151_CR28","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1182\/blood-2002-07-2119","volume":"101","author":"JA Martinez-Climent","year":"2003","unstructured":"Martinez-Climent JA, Alizadeh AA, Segraves R, Blesa D, Rubio-Moscardo F, Albertson DG et al (2003) Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations. Blood 101(8):3109\u20133117. https:\/\/doi.org\/10.1182\/blood-2002-07-2119","journal-title":"Blood"},{"issue":"3","key":"3151_CR29","first-page":"381","volume":"18","author":"EA Gall","year":"1942","unstructured":"Gall EA, Mallory TB (1942) Malignant lymphoma: a clinico-pathologic survey of 618 cases. Am J Pathol 18(3):381\u2013429","journal-title":"Am J Pathol"},{"issue":"14","key":"3151_CR30","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1200\/JCO.2010.32.7577","volume":"29","author":"S Montoto","year":"2011","unstructured":"Montoto S, Fitzgibbon J (2011) Transformation of indolent B-cell lymphomas. J Clin Oncol 29(14):1827\u20131834. https:\/\/doi.org\/10.1200\/JCO.2010.32.7577","journal-title":"J Clin Oncol"},{"issue":"15","key":"3151_CR31","doi-asserted-by":"publisher","first-page":"3553","DOI":"10.1182\/blood-2008-08-174839","volume":"113","author":"E Carlotti","year":"2009","unstructured":"Carlotti E, Wrench D, Matthews J, Iqbal S, Davies A, Norton A et al (2009) Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone. Blood 113(15):3553\u20133557. https:\/\/doi.org\/10.1182\/blood-2008-08-174839","journal-title":"Blood"},{"issue":"7","key":"3151_CR32","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100(7):3983\u20133988. https:\/\/doi.org\/10.1073\/pnas.0530291100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3151_CR33","doi-asserted-by":"publisher","unstructured":"Kridel R, Sehn LH, Gascoyne RD (2017) Can histologic transformation of follicular lymphoma be predicted and prevented? Blood. https:\/\/doi.org\/10.1182\/blood-2017-03-691345","DOI":"10.1182\/blood-2017-03-691345"},{"issue":"9","key":"3151_CR34","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1111\/j.1349-7006.2008.00873.x","volume":"99","author":"AM Maeshima","year":"2008","unstructured":"Maeshima AM, Omatsu M, Nomoto J, Maruyama D, Kim SW, Watanabe T et al (2008) Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma: morphological, immunohistochemical, and FISH analyses. Cancer Sci 99(9):1760\u20131768. https:\/\/doi.org\/10.1111\/j.1349-7006.2008.00873.x","journal-title":"Cancer Sci"},{"issue":"7","key":"3151_CR35","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1200\/JCO.2003.07.070","volume":"21","author":"M Ladetto","year":"2003","unstructured":"Ladetto M, Drandi D, Compagno M, Astolfi M, Volpato F, Voena C et al (2003) PCR-detectable nonneoplastic Bcl-2\/IgH rearrangements are common in normal subjects and cancer patients at diagnosis but rare in subjects treated with chemotherapy. J Clin Oncol 21(7):1398\u20131403. https:\/\/doi.org\/10.1200\/JCO.2003.07.070","journal-title":"J Clin Oncol"},{"issue":"4","key":"3151_CR36","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1200\/JCO.1996.14.4.1333","volume":"14","author":"G Dolken","year":"1996","unstructured":"Dolken G, Illerhaus G, Hirt C, Mertelsmann R (1996) BCL-2\/JH rearrangements in circulating B cells of healthy blood donors and patients with nonmalignant diseases. J Clin Oncol 14(4):1333\u20131344. https:\/\/doi.org\/10.1200\/JCO.1996.14.4.1333","journal-title":"J Clin Oncol"},{"issue":"2","key":"3151_CR37","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1182\/blood.V98.2.486","volume":"98","author":"M Yasukawa","year":"2001","unstructured":"Yasukawa M, Bando S, Dolken G, Sada E, Yakushijin Y, Fujita S et al (2001) Low frequency of BCL-2\/J(H) translocation in peripheral blood lymphocytes of healthy Japanese individuals. Blood 98(2):486\u2013488","journal-title":"Blood"},{"issue":"9","key":"3151_CR38","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1182\/blood-2012-09-457283","volume":"121","author":"MR Green","year":"2013","unstructured":"Green MR, Gentles AJ, Nair RV, Irish JM, Kihira S, Liu CL et al (2013) Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. Blood 121(9):1604\u20131611. https:\/\/doi.org\/10.1182\/blood-2012-09-457283","journal-title":"Blood"},{"issue":"7337","key":"3151_CR39","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nature09730","volume":"471","author":"L Pasqualucci","year":"2011","unstructured":"Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V et al (2011) Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 471(7337):189\u2013195. https:\/\/doi.org\/10.1038\/nature09730","journal-title":"Nature"},{"issue":"3","key":"3151_CR40","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2519\/jospt.2004.34.3.116","volume":"34","author":"MA Sherry","year":"2004","unstructured":"Sherry MA, Best TM (2004) A comparison of 2 rehabilitation programs in the treatment of acute hamstring strains. J Orthop Sports Phys Ther 34(3):116\u2013125. https:\/\/doi.org\/10.2519\/jospt.2004.34.3.116","journal-title":"J Orthop Sports Phys Ther"},{"issue":"18","key":"3151_CR41","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1182\/blood-2015-06-649905","volume":"126","author":"R Kridel","year":"2015","unstructured":"Kridel R, Mottok A, Farinha P, Ben-Neriah S, Ennishi D, Zheng Y et al (2015) Cell of origin of transformed follicular lymphoma. Blood 126(18):2118\u20132127. https:\/\/doi.org\/10.1182\/blood-2015-06-649905","journal-title":"Blood"},{"issue":"4","key":"3151_CR42","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.cell.2004.08.006","volume":"118","author":"AR Ramiro","year":"2004","unstructured":"Ramiro AR, Jankovic M, Eisenreich T, Difilippantonio S, Chen-Kiang S, Muramatsu M et al (2004) AID is required for c-myc\/IgH chromosome translocations in vivo. Cell 118(4):431\u2013438. https:\/\/doi.org\/10.1016\/j.cell.2004.08.006","journal-title":"Cell"},{"issue":"3","key":"3151_CR43","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1182\/blood.V80.3.758.758","volume":"80","author":"T Yano","year":"1992","unstructured":"Yano T, Jaffe ES, Longo DL, Raffeld MMYC (1992) Rearrangements in histologically progressed follicular lymphomas. Blood 80(3):758\u2013767","journal-title":"Blood"},{"issue":"4","key":"3151_CR44","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1182\/blood-2002-08-2482","volume":"102","author":"T Akasaka","year":"2003","unstructured":"Akasaka T, Lossos IS, Levy R (2003) BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. Blood 102(4):1443\u20131448. https:\/\/doi.org\/10.1182\/blood-2002-08-2482","journal-title":"Blood"},{"issue":"3","key":"3151_CR45","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1349-7006.2011.02186.x","volume":"103","author":"H Shikata","year":"2012","unstructured":"Shikata H, Yakushijin Y, Matsushita N, Sakai A, Sugita A, Nakamura N et al (2012) Role of activation-induced cytidine deaminase in the progression of follicular lymphoma. Cancer Sci 103(3):415\u2013421. https:\/\/doi.org\/10.1111\/j.1349-7006.2011.02186.x","journal-title":"Cancer Sci"},{"issue":"6","key":"3151_CR46","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","volume":"20","author":"M Challa-Malladi","year":"2011","unstructured":"Challa-Malladi M, Lieu YK, Califano O, Holmes AB, Bhagat G, Murty VV et al (2011) Combined genetic inactivation of beta2-microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. Cancer Cell 20(6):728\u2013740. https:\/\/doi.org\/10.1016\/j.ccr.2011.11.006","journal-title":"Cancer Cell"},{"issue":"14","key":"3151_CR47","first-page":"3894","volume":"63","author":"LA Smit","year":"2003","unstructured":"Smit LA, Bende RJ, Aten J, Guikema JE, Aarts WM, van Noesel CJ (2003) Expression of activation-induced cytidine deaminase is confined to B-cell non-Hodgkin's lymphomas of germinal-center phenotype. Cancer Res 63(14):3894\u20133898","journal-title":"Cancer Res"},{"issue":"4","key":"3151_CR48","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/sj.leu.2403323","volume":"18","author":"MS Hardianti","year":"2004","unstructured":"Hardianti MS, Tatsumi E, Syampurnawati M, Furuta K, Saigo K, Nakamachi Y et al (2004) Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL. Leukemia 18(4):826\u2013831. https:\/\/doi.org\/10.1038\/sj.leu.2403323","journal-title":"Leukemia"},{"issue":"12","key":"3151_CR49","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1093\/carcin\/bgm201","volume":"28","author":"P Perez-Duran","year":"2007","unstructured":"Perez-Duran P, de Yebenes VG, Ramiro AR (2007) Oncogenic events triggered by AID, the adverse effect of antibody diversification. Carcinogenesis 28(12):2427\u20132433. https:\/\/doi.org\/10.1093\/carcin\/bgm201","journal-title":"Carcinogenesis"},{"issue":"9","key":"3151_CR50","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/ng.892","volume":"43","author":"L Pasqualucci","year":"2011","unstructured":"Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A et al (2011) Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 43(9):830\u2013837. https:\/\/doi.org\/10.1038\/ng.892","journal-title":"Nat Genet"},{"issue":"32","key":"3151_CR51","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1200\/JCO.2008.16.0283","volume":"26","author":"AJ Al-Tourah","year":"2008","unstructured":"Al-Tourah AJ, Gill KK, Chhanabhai M, Hoskins PJ, Klasa RJ, Savage KJ et al (2008) Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma. J Clin Oncol 26(32):5165\u20135169. https:\/\/doi.org\/10.1200\/JCO.2008.16.0283","journal-title":"J Clin Oncol"},{"issue":"22","key":"3151_CR52","doi-asserted-by":"publisher","first-page":"3462","DOI":"10.1182\/blood-2013-12-545954","volume":"123","author":"J Tellier","year":"2014","unstructured":"Tellier J, Menard C, Roulland S, Martin N, Monvoisin C, Chasson L et al (2014) Human t(14;18)positive germinal center B cells: a new step in follicular lymphoma pathogenesis? Blood 123(22):3462\u20133465. https:\/\/doi.org\/10.1182\/blood-2013-12-545954","journal-title":"Blood"},{"issue":"4","key":"3151_CR53","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1200\/JCO.1997.15.4.1587","volume":"15","author":"Y Bastion","year":"1997","unstructured":"Bastion Y, Sebban C, Berger F, Felman P, Salles G, Dumontet C et al (1997) Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. J Clin Oncol 15(4):1587\u20131594. https:\/\/doi.org\/10.1200\/JCO.1997.15.4.1587","journal-title":"J Clin Oncol"},{"issue":"7","key":"3151_CR54","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1200\/JCO.1995.13.7.1726","volume":"13","author":"AR Yuen","year":"1995","unstructured":"Yuen AR, Kamel OW, Halpern J, Horning SJ (1995) Long-term survival after histologic transformation of low-grade follicular lymphoma. J Clin Oncol 13(7):1726\u20131733","journal-title":"J Clin Oncol"},{"issue":"11","key":"3151_CR55","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.3109\/10428194.2014.885513","volume":"55","author":"L Mozessohn","year":"2014","unstructured":"Mozessohn L, Cheung MC, Crump M, Buckstein R, Berinstein N, Imrie K et al (2014) Chemoimmunotherapy resistant follicular lymphoma: predictors of resistance, association with transformation and prognosis. Leuk Lymphoma 55(11):2502\u20132507. https:\/\/doi.org\/10.3109\/10428194.2014.885513","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"3151_CR56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00129039-200406000-00001","volume":"12","author":"Y Natkunam","year":"2004","unstructured":"Natkunam Y, Soslow R, Matolcsy A, Dolezal M, Bhargava V, Knowles DM et al (2004) Immunophenotypic and genotypic characterization of progression in follicular lymphomas. Appl Immunohistochem Mol Morphol 12(2):97\u2013104","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"20","key":"3151_CR57","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R et al (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375\u20132390. https:\/\/doi.org\/10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"issue":"6","key":"3151_CR58","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1309\/AJCPWY1SGJ9IEAOR","volume":"134","author":"I Ouansafi","year":"2010","unstructured":"Ouansafi I, He B, Fraser C, Nie K, Mathew S, Bhanji R et al (2010) Transformation of follicular lymphoma to plasmablastic lymphoma with c-myc gene rearrangement. Am J Clin Pathol 134(6):972\u2013981. https:\/\/doi.org\/10.1309\/AJCPWY1SGJ9IEAOR","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"3151_CR59","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1755-8166-6-34","volume":"6","author":"Y Ning","year":"2013","unstructured":"Ning Y, Foss A, Kimball AS, Neill N, Matz T, Schultz R (2013) Characterization of a case of follicular lymphoma transformed into B-lymphoblastic leukemia. Mol Cytogenet 6(1):34. https:\/\/doi.org\/10.1186\/1755-8166-6-34","journal-title":"Mol Cytogenet"},{"key":"3151_CR60","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1182\/asheducation-2011.1.506","volume":"2011","author":"ES Jaffe","year":"2011","unstructured":"Jaffe ES, Pittaluga S (2011) Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification. Hematol Am Soc Hematol Educ Program 2011:506\u2013514. https:\/\/doi.org\/10.1182\/asheducation-2011.1.506","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"7","key":"3151_CR61","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1093\/annonc\/mdw185","volume":"27","author":"K Koch","year":"2016","unstructured":"Koch K, Hoster E, Ziepert M, Unterhalt M, Ott G, Rosenwald A et al (2016) Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL. Ann Oncol 27(7):1323\u20131329. https:\/\/doi.org\/10.1093\/annonc\/mdw185","journal-title":"Ann Oncol"},{"issue":"11","key":"3151_CR62","first-page":"4649","volume":"29","author":"W Gollub","year":"2009","unstructured":"Gollub W, Stassek B, Huckhagel T, Bernd HW, Krokowski M, Merz H et al (2009) BCL6-translocations affect the phenotype of follicular lymphomas only in the absence of t(14;18)IgH\/BCL2. Anticancer Res 29(11):4649\u20134655","journal-title":"Anticancer Res"},{"issue":"10","key":"3151_CR63","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1016\/j.humpath.2014.06.019","volume":"45","author":"L Xerri","year":"2014","unstructured":"Xerri L, Bachy E, Fabiani B, Canioni D, Chassagne-Clement C, Dartigues-Cuilleres P et al (2014) Identification of MUM1 as a prognostic immunohistochemical marker in follicular lymphoma using computerized image analysis. Hum Pathol 45(10):2085\u20132093. https:\/\/doi.org\/10.1016\/j.humpath.2014.06.019","journal-title":"Hum Pathol"},{"issue":"11","key":"3151_CR64","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1182\/blood-2013-05-500595","volume":"123","author":"A Bouska","year":"2014","unstructured":"Bouska A, McKeithan TW, Deffenbacher KE, Lachel C, Wright GW, Iqbal J et al (2014) Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma. Blood 123(11):1681\u20131690. https:\/\/doi.org\/10.1182\/blood-2013-05-500595","journal-title":"Blood"},{"issue":"7","key":"3151_CR65","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1182\/blood-2006-09-045989","volume":"109","author":"K Karube","year":"2007","unstructured":"Karube K, Guo Y, Suzumiya J, Sugita Y, Nomura Y, Yamamoto K et al (2007) CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features. Blood 109(7):3076\u20133079. https:\/\/doi.org\/10.1182\/blood-2006-09-045989","journal-title":"Blood"},{"issue":"2","key":"3151_CR66","doi-asserted-by":"publisher","first-page":"325","DOI":"10.17219\/acem\/31804","volume":"24","author":"S Novelli","year":"2015","unstructured":"Novelli S, Briones J, Flotats A, Sierra J (2015) PET\/CT assessment of follicular lymphoma and high grade B cell lymphoma\u2014good correlation with clinical and histological features at diagnosis. Adv Clin Exp Med 24(2):325\u2013330. https:\/\/doi.org\/10.17219\/acem\/31804","journal-title":"Adv Clin Exp Med"},{"issue":"8","key":"3151_CR67","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1093\/annonc\/mdt137","volume":"24","author":"S Luminari","year":"2013","unstructured":"Luminari S, Biasoli I, Arcaini L, Versari A, Rusconi C, Merli F et al (2013) The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi. Ann Oncol 24(8):2108\u20132112. https:\/\/doi.org\/10.1093\/annonc\/mdt137","journal-title":"Ann Oncol"},{"issue":"44","key":"3151_CR68","doi-asserted-by":"publisher","first-page":"6427","DOI":"10.3748\/wjg.v18.i44.6427","volume":"18","author":"M Iwamuro","year":"2012","unstructured":"Iwamuro M, Okada H, Takata K, Shinagawa K, Fujiki S, Shiode J et al (2012) Diagnostic role of 18F-fluorodeoxyglucose positron emission tomography for follicular lymphoma with gastrointestinal involvement. World J Gastroenterol 18(44):6427\u20136436; discussion p 6434. https:\/\/doi.org\/10.3748\/wjg.v18.i44.6427","journal-title":"World J Gastroenterol"},{"issue":"27","key":"3151_CR69","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059\u20133068. https:\/\/doi.org\/10.1200\/JCO.2013.54.8800","journal-title":"J Clin Oncol"},{"issue":"27","key":"3151_CR70","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1200\/JCO.2013.53.5229","volume":"32","author":"SF Barrington","year":"2014","unstructured":"Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Mueller SP et al (2014) Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 32(27):3048\u20133058. https:\/\/doi.org\/10.1200\/JCO.2013.53.5229","journal-title":"J Clin Oncol"},{"issue":"4","key":"3151_CR71","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1080\/10428194.2016.1213824","volume":"58","author":"I Wong-Sefidan","year":"2017","unstructured":"Wong-Sefidan I, Byrtek M, Zhou X, Friedberg JW, Flowers CR, Zelenetz AD et al (2017) [18F] Positron emission tomography response after rituximab-containing induction therapy in follicular lymphoma is an independent predictor of survival after adjustment for FLIPI in academic and community-based practice. Leuk Lymphoma 58(4):809\u2013815. https:\/\/doi.org\/10.1080\/10428194.2016.1213824","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"3151_CR72","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1182\/blood-2014-06-582650","volume":"125","author":"M Yildiz","year":"2015","unstructured":"Yildiz M, Li H, Bernard D, Amin NA, Ouillette P, Jones S et al (2015) Activating STAT6 mutations in follicular lymphoma. Blood 125(4):668\u2013679. https:\/\/doi.org\/10.1182\/blood-2014-06-582650","journal-title":"Blood"},{"issue":"21","key":"3151_CR73","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1200\/JCO.2005.12.072","volume":"23","author":"H Schoder","year":"2005","unstructured":"Schoder H, Noy A, Gonen M, Weng L, Green D, Erdi YE et al (2005) Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. J Clin Oncol 23(21):4643\u20134651. https:\/\/doi.org\/10.1200\/JCO.2005.12.072","journal-title":"J Clin Oncol"},{"issue":"3","key":"3151_CR74","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3324\/haematol.12013","volume":"93","author":"C Bodet-Milin","year":"2008","unstructured":"Bodet-Milin C, Kraeber-Bodere F, Moreau P, Campion L, Dupas B, Le Gouill S (2008) Investigation of FDG-PET\/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma. Haematologica 93(3):471\u2013472. https:\/\/doi.org\/10.3324\/haematol.12013","journal-title":"Haematologica"},{"issue":"3","key":"3151_CR75","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/annonc\/mdn657","volume":"20","author":"A Noy","year":"2009","unstructured":"Noy A, Schoder H, Gonen M, Weissler M, Ertelt K, Cohler C et al (2009) The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL). Ann Oncol 20(3):508\u2013512. https:\/\/doi.org\/10.1093\/annonc\/mdn657","journal-title":"Ann Oncol"},{"issue":"10","key":"3151_CR76","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1093\/annonc\/mdl162","volume":"17","author":"E Gine","year":"2006","unstructured":"Gine E, Montoto S, Bosch F, Arenillas L, Mercadal S, Villamor N et al (2006) The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma. Ann Oncol 17(10):1539\u20131545. https:\/\/doi.org\/10.1093\/annonc\/mdl162","journal-title":"Ann Oncol"},{"issue":"2","key":"3151_CR77","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1365-2141.2012.09054.x","volume":"157","author":"A Conconi","year":"2012","unstructured":"Conconi A, Ponzio C, Lobetti-Bodoni C, Motta M, Rancoita PM, Stathis A et al (2012) Incidence, risk factors and outcome of histological transformation in follicular lymphoma. Br J Haematol 157(2):188\u2013196. https:\/\/doi.org\/10.1111\/j.1365-2141.2012.09054.x","journal-title":"Br J Haematol"},{"issue":"4","key":"3151_CR78","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S1470-2045(14)70027-0","volume":"15","author":"KM Ardeshna","year":"2014","unstructured":"Ardeshna KM, Qian W, Smith P, Braganca N, Lowry L, Patrick P et al (2014) Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial. Lancet Oncol 15(4):424\u2013435. https:\/\/doi.org\/10.1016\/S1470-2045(14)70027-0","journal-title":"Lancet Oncol"},{"key":"3151_CR79","doi-asserted-by":"crossref","unstructured":"Federico M CD, Marcheselli L, Tarantino V, Sarkozy C, Lopez Guillermo A, Wondergem M, Kimby E, Rusconi C,. Zucca E, Montoto S, da Silva MG, Aurer I, Paszkiewicz-Kozik E, Cartron G, Morschhauser F, Alcoceba M, Chamuleau M, Lockmer S, Minoia C, Issa D, Alonso S, Conte L, Salles G, Coiffier B (2017) The risk of transformation offollicular lymphoma\u201ctransformed\u201d by rituximab: the Aristotle study promoted by the European Lymphoma Institute. Hematol Oncol 35, issue supplement S2(June 2017): 115-116. e-pub ahead of print http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hon.2437_104\/e.pdf ;","DOI":"10.1002\/hon.2437_104"},{"issue":"2","key":"3151_CR80","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3109\/10428194.2013.802778","volume":"55","author":"BE Wahlin","year":"2014","unstructured":"Wahlin BE, Sundstrom C, Sander B, Christensson B, Jeppsson-Ahlberg A, Hjalmarsson E et al (2014) Higher World Health Organization grades of follicular lymphoma correlate with better outcome in two Nordic Lymphoma Group trials of rituximab without chemotherapy. Leuk Lymphoma 55(2):288\u2013295. https:\/\/doi.org\/10.3109\/10428194.2013.802778","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"3151_CR81","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1093\/annonc\/mdp460","volume":"21","author":"JW Sweetenham","year":"2010","unstructured":"Sweetenham JW, Goldman B, LeBlanc ML, Cook JR, Tubbs RR, Press OW et al (2010) Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group Study. Ann Oncol 21(6):1196\u20131202. https:\/\/doi.org\/10.1093\/annonc\/mdp460","journal-title":"Ann Oncol"},{"issue":"1","key":"3151_CR82","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1182\/blood-2008-02-140616","volume":"113","author":"KJ Cheung","year":"2009","unstructured":"Cheung KJ, Shah SP, Steidl C, Johnson N, Relander T, Telenius A et al (2009) Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances. Blood 113(1):137\u2013148. https:\/\/doi.org\/10.1182\/blood-2008-02-140616","journal-title":"Blood"},{"issue":"2","key":"3151_CR83","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1056\/NEJM198701083160204","volume":"316","author":"JJ Yunis","year":"1987","unstructured":"Yunis JJ, Frizzera G, Oken MM, McKenna J, Theologides A, Arnesen M (1987) Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. N Engl J Med 316(2):79\u201384. https:\/\/doi.org\/10.1056\/NEJM198701083160204","journal-title":"N Engl J Med"},{"issue":"4","key":"3151_CR84","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1182\/blood.V84.4.1043.1043","volume":"84","author":"H Tilly","year":"1994","unstructured":"Tilly H, Rossi A, Stamatoullas A, Lenormand B, Bigorgne C, Kunlin A et al (1994) Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood 84(4):1043\u20131049","journal-title":"Blood"},{"issue":"9","key":"3151_CR85","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1182\/blood-2010-03-272278","volume":"116","author":"MB Eide","year":"2010","unstructured":"Eide MB, Liestol K, Lingjaerde OC, Hystad ME, Kresse SH, Meza-Zepeda L et al (2010) Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones. Blood 116(9):1489\u20131497. https:\/\/doi.org\/10.1182\/blood-2010-03-272278","journal-title":"Blood"},{"issue":"2","key":"3151_CR86","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1182\/blood.V96.2.635","volume":"96","author":"IS Lossos","year":"2000","unstructured":"Lossos IS, Levy R (2000) Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5\u2032 noncoding regulatory region of the BCL-6 gene. Blood 96(2):635\u2013639","journal-title":"Blood"},{"issue":"10","key":"3151_CR87","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1182\/blood.V88.10.3937.bloodjournal88103937","volume":"88","author":"A Matolcsy","year":"1996","unstructured":"Matolcsy A, Casali P, Warnke RA, Knowles DM (1996) Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene. Blood 88(10):3937\u20133944","journal-title":"Blood"},{"issue":"8","key":"3151_CR88","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/sj.leu.2403802","volume":"19","author":"AJ Davies","year":"2005","unstructured":"Davies AJ, Lee AM, Taylor C, Clear AJ, Goff LK, Iqbal S et al (2005) A limited role for TP53 mutation in the transformation of follicular lymphoma to diffuse large B-cell lymphoma. Leukemia 19(8):1459\u20131465. https:\/\/doi.org\/10.1038\/sj.leu.2403802","journal-title":"Leukemia"},{"issue":"7","key":"3151_CR89","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1182\/blood.V82.7.1994.1994","volume":"82","author":"CA Sander","year":"1993","unstructured":"Sander CA, Yano T, Clark HM, Harris C, Longo DL, Jaffe ES et al (1993) p53 mutation is associated with progression in follicular lymphomas. Blood 82(7):1994\u20132004","journal-title":"Blood"},{"issue":"12","key":"3151_CR90","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.1182\/blood.V91.12.4677","volume":"91","author":"KS Elenitoba-Johnson","year":"1998","unstructured":"Elenitoba-Johnson KS, Gascoyne RD, Lim MS, Chhanabai M, Jaffe ES, Raffeld M (1998) Homozygous deletions at chromosome 9p21 involving p16 and p15 are associated with histologic progression in follicle center lymphoma. Blood 91(12):4677\u20134685","journal-title":"Blood"},{"issue":"9","key":"3151_CR91","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","volume":"16","author":"A Pastore","year":"2015","unstructured":"Pastore A, Jurinovic V, Kridel R, Hoster E, Staiger AM, Szczepanowski M et al (2015) Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. Lancet Oncol 16(9):1111\u20131122. https:\/\/doi.org\/10.1016\/S1470-2045(15)00169-2","journal-title":"Lancet Oncol"},{"issue":"2","key":"3151_CR92","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1093\/annonc\/mds433","volume":"24","author":"P Bains","year":"2013","unstructured":"Bains P, Al Tourah A, Campbell BA, Pickles T, Gascoyne RD, Connors JM et al (2013) Incidence of transformation to aggressive lymphoma in limited-stage follicular lymphoma treated with radiotherapy. Ann Oncol 24(2):428\u2013432. https:\/\/doi.org\/10.1093\/annonc\/mds433","journal-title":"Ann Oncol"},{"issue":"8","key":"3151_CR93","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1080\/10428194.2016.1265114","volume":"58","author":"M Gleeson","year":"2017","unstructured":"Gleeson M, Hawkes EA, Peckitt C, Wotherspoon A, Attygalle A, Sharma B et al (2017) Outcomes for transformed follicular lymphoma in the rituximab era: the Royal Marsden experience 2003-2013. Leuk Lymphoma 58(8):1805\u20131813. https:\/\/doi.org\/10.1080\/10428194.2016.1265114","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"3151_CR94","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00277-015-2303-5","volume":"94","author":"K Lerch","year":"2015","unstructured":"Lerch K, Meyer AH, Stroux A, Hirt C, Keller U, Viardot A et al (2015) Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis. Ann Hematol 94(6):981\u2013988. https:\/\/doi.org\/10.1007\/s00277-015-2303-5","journal-title":"Ann Hematol"},{"issue":"3","key":"3151_CR95","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1200\/JCO.2001.19.3.727","volume":"19","author":"CD Williams","year":"2001","unstructured":"Williams CD, Harrison CN, Lister TA, Norton AJ, Blystad AK, Coiffier B et al (2001) High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry. J Clin Oncol 19(3):727\u2013735. https:\/\/doi.org\/10.1200\/JCO.2001.19.3.727","journal-title":"J Clin Oncol"},{"issue":"9","key":"3151_CR96","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1200\/JCO.2012.44.0693","volume":"31","author":"D Villa","year":"2013","unstructured":"Villa D, Crump M, Panzarella T, Savage KJ, Toze CL, Stewart DA et al (2013) Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group. J Clin Oncol 31(9):1164\u20131171. https:\/\/doi.org\/10.1200\/JCO.2012.44.0693","journal-title":"J Clin Oncol"},{"issue":"2","key":"3151_CR97","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-2141.2005.05755.x","volume":"131","author":"RT Doocey","year":"2005","unstructured":"Doocey RT, Toze CL, Connors JM, Nevill TJ, Gascoyne RD, Barnett MJ et al (2005) Allogeneic haematopoietic stem-cell transplantation for relapsed and refractory aggressive histology non-Hodgkin lymphoma. Br J Haematol 131(2):223\u2013230. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05755.x","journal-title":"Br J Haematol"},{"issue":"4","key":"3151_CR98","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1182\/blood.V84.4.1050.1050","volume":"84","author":"V Ratanatharathorn","year":"1994","unstructured":"Ratanatharathorn V, Uberti J, Karanes C, Abella E, Lum LG, Momin F et al (1994) Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin's lymphoma. Blood 84(4):1050\u20131055","journal-title":"Blood"},{"issue":"10","key":"3151_CR99","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/bmt.2012.10","volume":"47","author":"N Reddy","year":"2012","unstructured":"Reddy N, Greer JP, Goodman S, Engelhardt B, Oluwole O, Jagasia MH et al (2012) Long-term outcome after autologous or allogeneic stem cell transplantation in patients with recurrent follicular lymphoma. Bone Marrow Transplant 47(10):1318\u20131320. https:\/\/doi.org\/10.1038\/bmt.2012.10","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"3151_CR100","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/bmt.2008.220","volume":"42","author":"KM Ramadan","year":"2008","unstructured":"Ramadan KM, Connors JM, Al-Tourah AJ, Song KW, Gascoyne RD, Barnett MJ et al (2008) Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term results. Bone Marrow Transplant 42(9):601\u2013608. https:\/\/doi.org\/10.1038\/bmt.2008.220","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"3151_CR101","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S1470-2045(11)70069-9","volume":"12","author":"F Peyrade","year":"2011","unstructured":"Peyrade F, Jardin F, Thieblemont C, Thyss A, Emile JF, Castaigne S et al (2011) Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial. Lancet Oncol 12(5):460\u2013468. https:\/\/doi.org\/10.1016\/S1470-2045(11)70069-9","journal-title":"Lancet Oncol"},{"issue":"4","key":"3151_CR102","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1200\/JCO.2013.49.7586","volume":"32","author":"PA Fields","year":"2014","unstructured":"Fields PA, Townsend W, Webb A, Counsell N, Pocock C, Smith P et al (2014) De novo treatment of diffuse large B-cell lymphoma with rituximab, cyclophosphamide, vincristine, gemcitabine, and prednisolone in patients with cardiac comorbidity: a United Kingdom National Cancer Research Institute trial. J Clin Oncol 32(4):282\u2013287. https:\/\/doi.org\/10.1200\/JCO.2013.49.7586","journal-title":"J Clin Oncol"},{"issue":"4","key":"3151_CR103","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1365-2141.2011.08781.x","volume":"154","author":"MS Czuczman","year":"2011","unstructured":"Czuczman MS, Vose JM, Witzig TE, Zinzani PL, Buckstein R, Polikoff J et al (2011) The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non-Hodgkin lymphoma of distinct histological origin. Br J Haematol 154(4):477\u2013481. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08781.x","journal-title":"Br J Haematol"},{"issue":"3","key":"3151_CR104","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1053\/j.seminhematol.2014.05.008","volume":"51","author":"MA Anderson","year":"2014","unstructured":"Anderson MA, Huang D, Roberts A (2014) Targeting BCL2 for the treatment of lymphoid malignancies. Semin Hematol 51(3):219\u2013227. https:\/\/doi.org\/10.1053\/j.seminhematol.2014.05.008","journal-title":"Semin Hematol"},{"issue":"4","key":"3151_CR105","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/bjh.12573","volume":"163","author":"A Aalipour","year":"2013","unstructured":"Aalipour A, Advani RH (2013) Bruton tyrosine kinase inhibitors: a promising novel targeted treatment for B cell lymphomas. Br J Haematol 163(4):436\u2013443. https:\/\/doi.org\/10.1111\/bjh.12573","journal-title":"Br J Haematol"},{"issue":"11","key":"3151_CR106","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1056\/NEJMoa1314583","volume":"370","author":"AK Gopal","year":"2014","unstructured":"Gopal AK, Kahl BS, de Vos S, Wagner-Johnston ND, Schuster SJ, Jurczak WJ et al (2014) PI3Kdelta inhibition by idelalisib in patients with relapsed indolent lymphoma. N Engl J Med 370(11):1008\u20131018. https:\/\/doi.org\/10.1056\/NEJMoa1314583","journal-title":"N Engl J Med"},{"issue":"4","key":"3151_CR107","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nrclinonc.2014.42","volume":"11","author":"JA Burger","year":"2014","unstructured":"Burger JA, Okkenhaug K (2014) Haematological cancer: idelalisib-targeting PI3Kdelta in patients with B-cell malignancies. Nat Rev Clin Oncol 11(4):184\u2013186. https:\/\/doi.org\/10.1038\/nrclinonc.2014.42","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"3151_CR108","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1200\/JCO.2012.46.8793","volume":"32","author":"JW Friedberg","year":"2014","unstructured":"Friedberg JW, Mahadevan D, Cebula E, Persky D, Lossos I, Agarwal AB et al (2014) Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas. J Clin Oncol 32(1):44\u201350. https:\/\/doi.org\/10.1200\/JCO.2012.46.8793","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-017-3151-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3151-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-017-3151-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T02:30:35Z","timestamp":1603161035000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-017-3151-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,18]]},"references-count":108,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["3151"],"URL":"https:\/\/doi.org\/10.1007\/s00277-017-3151-2","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,18]]}}}